CorMedix Inc. (CRMD) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for CorMedix Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$8.20
+2.50% today
Market cap
$624M
Overall quality
82/100
Kronos AI 30-day
−0.1%
4 of 8 simulated paths end higher
CorMedix Inc. (CRMD) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $624M. It trades at $8.20, up 2.50% today, at 3.4 times earnings. Its overall quality score is 82 out of 100, ranked against the whole US market. 4 analysts' average target of $14.60 implies +78.0% from today's price. Kronos AI's 30-day forecast is −0.1% (4 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $14.60 |
| Low – high | $13.00 – $16.00 |
| Analysts | 4 |
| Upside to average | +78.0% |
Kronos AI 30-day forecast
| Expected close | $7.99 (−0.1%) |
| Likely range | −1.6% … +9.9% |
| As of | 2026-10-27 |
4 of 8 simulated paths end higher.
Quality scores
| Profitability | 94 |
| Solvency | 70 |
| Growth | 81 |
| Overall | 82 |
| P/E | 3.4 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.